BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6183027)

  • 21. Circadian and day-to-day variation of prostatic acid phosphatase.
    Nissenkorn I; Mickey DD; Miller DB; Soloway MS
    J Urol; 1982 Jun; 127(6):1122-4. PubMed ID: 6177878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A discrete analyzer (ABA-100) method for prostatic acid phosphatase with thymolphthalein monophosphate as substrate.
    Chu SY; Turkington VE
    Clin Chem; 1982 Feb; 28(2):389-90. PubMed ID: 7055971
    [No Abstract]   [Full Text] [Related]  

  • 23. Radioimmunoassayable prostate-specific acid phosphatase in peripheral and bone marrow sera compared in diagnosis of prostatic cancer patients.
    Vihko P; Kontturi M; Lukkarinen O; Vihko R
    J Urol; 1982 Oct; 128(4):739-41. PubMed ID: 6183458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioimmunoassay of serum prostatic acid phosphatase in prostatic carcinoma. A comparative study with an enzymatic assay.
    Ishibe T
    Acta Urol Belg; 1981 Jan; 49(1):64-72. PubMed ID: 6163343
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical evaluation of immunological methods for detection for serum prostatic acid phosphatase.
    Pontes JE; Choe BK; Rose NR; Ercole C; Pierce JM
    J Urol; 1981 Sep; 126(3):363-5. PubMed ID: 6168779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
    Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
    Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical assay for prostatic acid phosphatase using choline phosphate as a substrate: comparison with thymolphthalein phosphate.
    Saini MS; Van Etten RL
    Prostate; 1981; 2(4):359-68. PubMed ID: 7329872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of manipulation of the prostate gland on serum prostate-specific acid phosphatase measured by radioimmunoassay.
    Vihko P; Lukkarinen O; Kontturi M; Vihko R
    Invest Urol; 1981 Mar; 18(5):334-6. PubMed ID: 6162819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioimmunoassay (RIA) for prostatic acid phosphatase in patients with prostatic carcinoma.
    Debruyne FM; van Munster PJ; van Groeninghen JC; Kirkels WJ
    Urol Res; 1984; 12(5):233-7. PubMed ID: 6083652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostatic acid phosphatase and prostatic cancer.
    Foti AG; Cooper JF; Herschman H
    Recent Results Cancer Res; 1979; 67():45-9. PubMed ID: 88065
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunochemical measurement of serum prostatic acid phosphatase (PAP). Clinical evaluation of radioimmunoassay and counter immunoelectrophoresis.
    Gupta MK; Rajaraman S; Gupta SK; Hewitt CB; Deodhar SD
    Am J Clin Pathol; 1981 Oct; 76(4):430-6. PubMed ID: 6170220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anatomoclinical and biologic correlations in prostatic pathology. Apropos of 150 case reports].
    Amiel J; Chevallier D; Peyrottes A; Benoliel J; Toubol J
    Ann Urol (Paris); 1989; 23(6):528-30. PubMed ID: 2482700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human prostatic acid phosphatases: II. A double--antibody radioimmunoassay.
    Choe BK; Pontes EJ; Morrison MK; Rose NR
    Arch Androl; 1978 May; 1(3):227-33. PubMed ID: 83815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current experience with radioimmunoassay techniques for prostatic acid phosphatase.
    Cooper JF; Finkle WD
    Prostate; 1980; 1(4):441-50. PubMed ID: 7279809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient high serum prostate-specific acid phosphatase measured by radioimmunoassay in prostatic infarction.
    Vihko P; Kontturi M
    Scand J Urol Nephrol; 1981; 15(3):213-4. PubMed ID: 7323740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [What is the use of the radioimmunoassay of prostatic acid phosphatase?].
    Luckacs B; Cohen L; Coloby P; Gattegno B; Michel F; Agnes E; Roland J; Thibault P
    J Urol (Paris); 1985; 91(4):211-4. PubMed ID: 2410516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical value of different methods for determination of acid phosphatase in prostatic cancer.
    Flüchter SH; Bichler KH; Harzmann R; Reuter MA; Mildner A
    Urol Int; 1982; 37(2):79-86. PubMed ID: 6180535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and clinical evaluation of two immunoassays for prostatic acid phosphatase in serum.
    de Vries GP; Sanders GT
    Am J Clin Pathol; 1982 Aug; 78(2):189-95. PubMed ID: 6179425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid radioimmunoassay for prostate-specific acid phosphatase in human serum.
    Vihko P; Kostama A; Jänne O; Sajanti E; Vihko R
    Clin Chem; 1980 Oct; 26(11):1544-7. PubMed ID: 6158382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
    Akimoto S; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.